Incannex Healthcare Inc. (IXHL): Shareholders' Equity
$13.39M
As of 2025-06-30
$75.23M
As of 2026-03-31
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $13.39M | +19.4% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $11.22M | -46.1% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $20.82M | n/a | 2024-09-30, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $13.39M | +19.4% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $41.98M | -54.5% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$37.0K | n/m |
Compare IXHL, ATNM, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗